Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer

BACKGROUND: Tumor mutation burden (TMB), DNA mismatch repair deficiency (dMMR), microsatellite instability (MSI), and PD‐L1 amplification (PD‐L1 AMP) may predict the efficacy of the PD‐1/PD‐L1 blockade. With the broadening landscape of immunotherapy use, it is important to identify patients who are...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Yuan‐sheng, Dai, Chun, Xu, Xiaoman, Cai, Xin, Wang, Guan, Wei, Jinwang, Wu, Angela, Sun, Wending, Jiao, Shunchang, Xu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712454/
https://www.ncbi.nlm.nih.gov/pubmed/31270941
http://dx.doi.org/10.1002/cam4.2381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712454/
https://www.ncbi.nlm.nih.gov/pubmed/31270941
http://dx.doi.org/10.1002/cam4.2381

Ejemplares similares